Concord Medical Services Holdings Limited (CCM) Key Metrics
CCM key metrics, 2016–2025
Fiscal year ended December 31, 2025 · Chinese yuanCCM returns How much profit the business earns on the capital it uses.
CCM financial health Debt, liquidity and how easily interest is covered.
CCM efficiency & capital use Working capital cycle and where the cash goes.
CCM returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CCM debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CCM cash returned to shareholders
CCM key metrics in Chinese yuan
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | — | — | — | — | −35.5% | — | −34.3% | −27.1% | −20.5% |
| Return on invested capital (ROIC) | −14.9% | −34.8% | −31.4% | −34.2% | −12.9% | −8.5% | −30.7% | −15.8% | −7.9% | −5.9% |
| Return on assets (ROA) | −1.4% | −4.8% | −4.9% | −8.0% | −4.7% | −8.4% | −6.9% | −5.8% | −8.5% | −7.7% |
| Return on tangible assets | −1.7% | −5.6% | −5.8% | −10.5% | −5.9% | −8.8% | −8.6% | −6.7% | −9.4% | −9.5% |
| Free cash flow margin | −63.7% | −210.6% | −73.0% | −127.2% | −230.6% | −333.0% | −451.8% | −420.6% | −79.3% | −43.1% |
| Financial health | ||||||||||
| Total debt | CN¥3.63B | CN¥3.93B | CN¥3.30B | CN¥3.24B | CN¥2.73B | CN¥2.35B | CN¥1.52B | CN¥938.1M | CN¥1.24B | CN¥1.19B |
| Cash & short-term investments | CN¥297.8M | CN¥350.8M | CN¥58.1M | CN¥158.3M | CN¥157.4M | CN¥334.3M | CN¥74.3M | CN¥454.7M | CN¥98.2M | CN¥189.9M |
| Net debt | CN¥3.34B | CN¥3.58B | CN¥3.24B | CN¥3.08B | CN¥2.58B | CN¥2.02B | CN¥1.45B | CN¥483.4M | CN¥1.14B | CN¥999.0M |
| Debt / equity | — | — | — | — | — | 0.98 | — | 2.14 | 1.33 | 1.02 |
| Debt / assets | 0.56 | 0.58 | 0.54 | 0.54 | 0.44 | 0.44 | 0.35 | 0.20 | 0.36 | 0.37 |
| Net debt / EBITDA | — | — | — | — | — | — | — | — | — | 46.46 |
| Current ratio | 0.48 | 0.46 | 0.32 | 0.68 | 0.73 | 1.32 | 0.45 | 1.41 | 1.00 | 1.26 |
| Quick ratio | 0.46 | 0.45 | 0.30 | 0.60 | 0.68 | 1.28 | 0.44 | 1.41 | 1.00 | 1.25 |
| Interest coverage | -1.6 | -2.8 | -2.8 | -4.4 | -6.2 | -3.8 | -15.2 | -6.5 | -2.4 | -1.9 |
| Working capital | −CN¥1.01B | −CN¥1.14B | −CN¥1.33B | −CN¥361.4M | −CN¥220.0M | CN¥163.9M | −CN¥345.0M | CN¥358.4M | CN¥3.0M | CN¥243.8M |
| Invested capital | CN¥1.23B | CN¥1.30B | CN¥1.12B | CN¥1.22B | CN¥1.21B | CN¥4.42B | CN¥1.33B | CN¥920.8M | CN¥2.08B | CN¥2.17B |
| Tangible asset value | CN¥643.4M | CN¥365.2M | CN¥848.3M | CN¥678.1M | CN¥1.09B | CN¥1.66B | CN¥1.15B | CN¥1.21B | CN¥559.2M | CN¥772.8M |
| Net current asset value | −CN¥3.76B | −CN¥4.12B | −CN¥3.69B | −CN¥3.23B | −CN¥2.90B | −CN¥2.26B | −CN¥2.13B | −CN¥1.08B | −CN¥1.34B | −CN¥802.0M |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | CN¥0 | CN¥0 | CN¥0 | CN¥285.8M |
| Share buybacks (net) | — | CN¥0 | — | — | — | — | — | CN¥0 | CN¥0 | CN¥30.4M |
| Capex / revenue | 19.8% | 107.0% | 21.5% | 81.3% | 156.6% | 230.0% | 353.4% | 400.4% | 87.3% | 25.9% |
| Capex / operating cash flow | — | — | — | — | — | — | — | — | 1,081.5% | — |
| Capex / depreciation | 0.61 | 3.14 | 0.90 | 2.89 | 7.31 | 6.39 | 10.65 | 13.99 | 3.05 | 0.91 |
| Stock-based compensation / revenue | 0.0% | 0.0% | 0.0% | −1.3% | 3.0% | 9.2% | 10.4% | 5.8% | 3.5% | 1.8% |
| SG&A / revenue | 57.6% | 118.0% | 71.9% | 78.9% | 82.7% | 143.8% | 174.1% | 164.3% | 85.0% | 60.7% |
| Efficiency | ||||||||||
| Days sales outstanding | 37.7 | 59.3 | 69.2 | 198.4 | 249.3 | 328.6 | 298.3 | 477.4 | 329.4 | 274.6 |
| Days of inventory on hand | 33.3 | 29.1 | 37.2 | 35.9 | 20.1 | 22.6 | 6.6 | 10.3 | 9.6 | 6.3 |
| Days payables outstanding | 133.8 | 129.5 | 82.0 | 72.8 | 40.7 | 23.4 | 11.7 | 10.7 | 5.2 | 1.8 |
| Cash conversion cycle (days) | -62.7 | -41.2 | 24.4 | 161.5 | 228.6 | 327.8 | 293.2 | 477.1 | 333.8 | 279.0 |
| Receivables turnover | 9.67 | 6.16 | 5.27 | 1.84 | 1.46 | 1.11 | 1.22 | 0.76 | 1.11 | 1.33 |
| Payables turnover | 2.73 | 2.82 | 4.45 | 5.01 | 8.96 | 15.60 | 31.24 | 34.22 | 70.59 | 201.37 |
| Inventory turnover | 10.95 | 12.55 | 9.81 | 10.16 | 18.18 | 16.18 | 55.66 | 35.51 | 38.17 | 58.36 |
| Asset turnover | 0.07 | 0.06 | 0.09 | 0.08 | 0.08 | 0.05 | 0.04 | 0.05 | 0.10 | 0.13 |
| Average receivables | CN¥47.6M | CN¥62.3M | CN¥101.9M | CN¥256.7M | CN¥331.7M | CN¥200.8M | CN¥162.1M | CN¥249.7M | CN¥298.7M | CN¥342.3M |
| Average payables | CN¥159.3M | CN¥164.3M | CN¥138.0M | CN¥124.6M | CN¥60.6M | CN¥13.5M | CN¥6.9M | CN¥5.0M | CN¥3.3M | CN¥1.4M |
| Average inventory | CN¥39.7M | CN¥36.9M | CN¥62.6M | CN¥61.5M | CN¥29.8M | CN¥13.0M | CN¥3.8M | CN¥4.8M | CN¥6.1M | CN¥4.9M |
| Intangibles / total assets | 18.4% | 18.6% | 14.8% | 22.3% | 26.6% | 13.8% | 17.3% | 23.1% | 13.2% | 14.2% |
Computed from CCM's annual financial statements (latest annual report filed April 29, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in Chinese yuan; data from EODHD. Averages use the opening and closing balance of each year.
CCM valuation and financial ratios
Concord Medical Services earned a return on invested capital of −14.9% in fiscal 2025. It ended the year with CN¥3.6 billion of debt and CN¥297.8 million in cash and short-term investments, net debt of CN¥3.3 billion.
See the CCM income statement, the CCM chart for price history, or the CCM stock overview for the latest quote and news.
CCM key metrics FAQ
What is Concord Medical Services's ROIC?
Concord Medical Services's return on invested capital was −14.9% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Concord Medical Services have?
Concord Medical Services had total debt of CN¥3.6 billion at the end of fiscal 2025.
What is Concord Medical Services's current ratio?
Concord Medical Services's current ratio was 0.48 at the end of fiscal 2025: current assets were 0.48 times current liabilities.